Teligent Pharma, Inc. recalls Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufacture…
- Recall date
- November 30, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0296-2022
- FDA classification
- Class II
- Brand / firm
- Teligent Pharma, Inc.
- Sold / distributed
- Distributed to a wholesaler in CO who further distributed Nationwide in the USA
Why it was recalled
Superpotent Drug: Minimally superpotent
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64
Get recall alerts
Free email alert whenever Teligent Pharma, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teligent Pharma, Inc.